FTC v. Pantron I Corp., 33 F.3d 1088 (1994)

FTC v. Pantron I Corp.


The Ninth Circuit held that a seller is liable for misrepresentation of its product's effectiveness if it can only be attributed to the placebo effect using acceptable standards of scientific research. Pantron claimed that it's product reduced hair loss, and cited two European studies to confirm its claim. The FTC claimed that the studies were not held to acceptable scientific research standards, and cited multiple US based studies that held to the contrary using double blind and placebo controlled process that was published in peer reviewed journals.

Full case and summary also available at: http://www.mlmlegal.com/legal-cases/FTC_v_PantronICorp.php

LOADING PDF: If there are any problems, click here to download the file.

Reference Info:Federal, Federal Circuit | United States

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Babener & Associates | Attorney Advertising

Written by:


Babener & Associates on:

JD Supra Readers' Choice 2016 Awards
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.